Literature DB >> 23187294

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations.

M Perugini, D G Iarossi, C H Kok, N Cummings, S M Diakiw, A L Brown, S Danner, P Bardy, L Bik To, A H Wei, I D Lewis, R J D'Andrea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23187294     DOI： 10.1038/leu.2012.346

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  9 in total

1.  Gadd45 in Normal Hematopoiesis and Leukemia.

Authors:  Dan A Liebermann
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.

Authors:  Arslon Humayun; Albert J Fornace
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Roles for GADD45 in Development and Cancer.

Authors:  Kishan Patel; Mary Grace Murray; Kelly A Whelan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome.

Authors:  P Tan; A Wei; S Mithraprabhu; N Cummings; H B Liu; M Perugini; K Reed; S Avery; S Patil; P Walker; P Mollee; A Grigg; R D'Andrea; A Dear; A Spencer
Journal:  Blood Cancer J       Date:  2014-01-10       Impact factor: 11.037

5.  Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.

Authors:  Kaushiki Mukherjee; Xiaojin Sha; Andrew Magimaidas; Silvia Maifrede; Tomasz Skorski; Ravi Bhatia; Barbara Hoffman; Dan A Liebermann
Journal:  Oncotarget       Date:  2017-02-14

6.  BjussuLAAO-II induces cytotoxicity and alters DNA methylation of cell-cycle genes in monocultured/co-cultured HepG2 cells.

Authors:  Ana Rita Thomazela Machado; Alexandre Ferro Aissa; Diego Luis Ribeiro; Rui Seabra Ferreira; Suely Vilela Sampaio; Lusânia Maria Greggi Antunes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-03-11

Review 7.  DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.

Authors:  A P Im; A R Sehgal; M P Carroll; B D Smith; A Tefferi; D E Johnson; M Boyiadzis
Journal:  Leukemia       Date:  2014-04-04       Impact factor: 12.883

8.  Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity.

Authors:  S Weng; S Matsuura; C T Mowery; S A Stoner; K Lam; D Ran; A G Davis; M-C Lo; D-E Zhang
Journal:  Leukemia       Date:  2016-06-15       Impact factor: 11.528

9.  Gadd45 stress sensors in suppression of leukemia.

Authors:  David L Wiest
Journal:  Oncotarget       Date:  2018-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.